Gastric Cancer research hub

Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors

This study is testing a new experimental medicine, AZD5863, for people with advanced stomach, oesophageal, or pancreatic cancer. It aims to see if the medicine is safe, what dose works best, and if it can help fight the cancer.